Heinz‐Josef Lenz
University of Southern California(US)Keck Hospital of USC(US)USC Norris Comprehensive Cancer Center(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology
Most-Cited Works
- → Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial(2012)2,847 cited
- → Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study(2017)2,758 cited
- → Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer(2018)2,022 cited
- → CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy(2017)1,564 cited
- → Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer(2015)1,395 cited
- → Colorectal cancer(2010)1,351 cited